AGM/EGMMay 7, 2026, 05:27 PM
Tonix Pharma Shareholders Approve Reverse Split Authority, ESOP
AI Summary
Tonix Pharmaceuticals Holding Corp. shareholders approved four proposals at their Annual Meeting on May 7, 2026. Key approvals include the authorization for the Board of Directors to implement a reverse stock split at a ratio between 1:2 and 1:250 within two years, and the adoption of the 2026 Stock Incentive Plan. Additionally, nine directors were elected to the Board, and PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal year 2026.
Key Highlights
- Shareholders approved authorization for Board to effect reverse stock splits (1:2 to 1:250) within two years.
- Shareholders approved the 2026 Stock Incentive Plan.
- Nine individuals were elected to the Board of Directors.
- PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal year 2026.
- 7,267,759 shares, representing 54.22% of outstanding common shares, were present at the Annual Meeting.